We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Thiamidol (isobutylamido thiazolyl resorcinol)
A cosmetic tyrosinase inhibitor found by screening 50,000 compounds against the HUMAN enzyme — and the rare brightener with head-to-head data against 4% hydroquinone.
Topical cosmetic ingredient — not a dietary supplement
Thiamidol is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Thiamidol studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality randomised trials published 2018–2024 with a typical study size of 48 participants.
Based on 9 studies · 5 RCTs · 2,128 total participants
Confidence
High confidenceBy outcome
Unusually good evidence for a cosmetic ingredient: a high-impact mechanism paper, multiple randomized trials, and head-to-head comparisons against both 4% hydroquinone and Kligman’s trio. Held at 6.5 because every head-to-head is a NON-INFERIORITY result rather than a win, the one study with a regression phase found the benefit did not persist after stopping, and the dedicated systematic review calls the evidence limited.
11 randomised trials
82% were about Thiamidol in an audit of 11 of them
Every randomised or controlled trial of Thiamidol indexed in PubMed, not a hand-picked subset. Meta-analyses and systematic reviews are deliberately excluded from this count: most of them cover many compounds at once, so counting them would inflate it.
PubMed · as of Sep 2026
Thiamidol is Beiersdorf’s depigmenting ingredient, identified in a 50,000-compound screen against recombinant human tyrosinase.
That screen is the point: most brightening ingredients were selected using MUSHROOM tyrosinase, and thiamidol demonstrates the two enzymes need different molecules — it inhibits the human enzyme a hundredfold more strongly than the mushroom one, while hydroquinone, arbutin and kojic acid are all weak against human tyrosinase.
Clinically it is genuinely evidenced for melasma and post-inflammatory hyperpigmentation, and in a head-to-head trial it matched 4% hydroquinone.
What the trials do not show is superiority, or persistence: the only study with a regression phase found the benefit gone 13-20 weeks after stopping, and its own systematic review calls the evidence limited.
Tyrosinase is the rate-limiting enzyme of melanin synthesis. Thiamidol inhibits the human enzyme at IC50 1.1 µmol/L but the mushroom enzyme only at 108 µmol/L. Most legacy brighteners were screened on mushroom tyrosinase, which is the stated reason so many of them underperform in skin.
In melanocyte culture thiamidol inhibited melanogenesis reversibly (IC50 0.9 µmol/L), where hydroquinone acted irreversibly. Reversibility is why this sits in cosmetics rather than under the restrictions hydroquinone carries.
No trial data in pregnancy. It is a cosmetic ingredient with minimal systemic exposure, but melasma in pregnancy is usually managed with sunscreen and time; discuss with a clinician.
Stacking depigmenters raises irritation, and irritation itself can drive post-inflammatory hyperpigmentation — the outcome being treated. Introduce one at a time.
Thiamidol has an evidence score of 6.5/10 — moderate evidence based on 9 indexed studies. A cosmetic tyrosinase inhibitor found by screening 50,000 compounds against the HUMAN enzyme — and the rare brightener with head-to-head data against 4% hydroquinone. Representative study: PMID 34525885.
The commonly studied dose of Thiamidol is Apply a thiamidol-containing serum or cream at 0.1-0.2% twice daily to the affected area, alongside daily broad-spectrum SPF 30 or higher. Continue 12-24 weeks.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
The best time to take Thiamidol is in split doses through the day. It can be taken on an empty stomach. The systematic review reads the effective regimen as 0.1-0.2% applied two to four times daily; the split-face dosing study compared four-times with twice daily.
Thiamidol is generally well-tolerated and considered safe for most healthy adults at recommended doses. Reported side effects are uncommon and include mild local irritation or stinging, dryness or desquamation. Use caution if any of these apply to you: Known hypersensitivity to resorcinol derivatives.
Sunscreen (SPF)
Mostly mechanism / observationalDaily broad-spectrum sunscreen — the single most evidence-based anti-aging skincare step there is, and the one most 'anti-aging' actives are really just trying to compensate for. The honest framing: this is the only topical on this list backed by a proper randomized controlled trial for skin aging itself. In the landmark Hughes 2013 trial (n=903), people randomized to daily sunscreen showed 24% less photoaging over 4.5 years — and no detectable increase in skin aging at all — while the mechanism (UV → matrix-metalloproteinase activation → collagen breakdown) is textbook. The same trial cohort also had less skin cancer. The honest caveats: the benefit is overwhelmingly prevention, not reversal of existing damage; real-world results depend entirely on applying enough and reapplying; and chemical (organic) UV filters are systemically absorbed above an FDA testing threshold (clinical significance unknown — mineral zinc-oxide/titanium-dioxide filters sidestep this). If you do one thing for your skin, it's this.
Tretinoin (Retin-A)
Mostly mechanism / observationalA prescription TOPICAL retinoid (Retin-A, Renova) — the acid form of vitamin A and the gold-standard, best-evidenced topical treatment for photoaging and acne. Multiple double-blind RCTs show it reduces fine wrinkles, mottled hyperpigmentation, and roughness over months, with histologic increases in dermal collagen. Caveats: retinoid dermatitis (irritation, peeling, dryness), photosensitivity, and it is CONTRAINDICATED IN PREGNANCY. Prescription drug, not a supplement; distinct from weaker OTC 'retinol' cosmetics.
Azelaic Acid
Mostly mechanism / observationalA topical skincare acid applied to the skin for rosacea, acne, and uneven tone — unusual among 'cosmetic' actives because it has genuine drug-grade evidence. Azelaic acid is a naturally occurring dicarboxylic acid that is anti-inflammatory, antimicrobial, and a tyrosinase inhibitor. It is sold both as an over-the-counter cosmetic (around 10%) AND as a 15-20% prescription medication. The honest framing: the strongest, best-replicated evidence — including double-blind phase III trials and a Cochrane review that rated it high-quality for papulopustular rosacea — used the PRESCRIPTION strengths (15-20%), not the ~10% OTC cosmetic form. It also has solid evidence for acne and melasma. Head-to-head it is beaten for acne (by benzoyl peroxide + clindamycin) and tends to cause more local irritation (burning, stinging) than several comparators. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route.
Tazarotene
Mostly mechanism / observationalA prescription topical retinoid — the strongest of the three approved for acne, and the one most likely to irritate.
Explore: Best supplements for Skin, Hair & BeautyBest supplements for Body Health
Reviewed by Dr. Baher Al Hakim · Last reviewed September 2026 · evidence from 9 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.